Safety Analysis of Chronic Intake of a β-alanine Supplement

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-21

Study Completion Date

2022-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Single-center, double-blind, placebo-controlled clinical trial with two arms (product and placebo) to analyze the safety of beta-alanine consumption in active people.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Analyze the Efficacy of Acute Intake With a β-alanine Supplement in Recreational Cyclists

NCT06180512

Beta Alanine Supplementation

COMPLETED NA

Study to Analyze the Aerobic Performance Efficacy of Chronic Intake With a β-alanine Supplement in Recreational Cyclists

NCT06167395

Beta Alanine Supplementation

COMPLETED NA

24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males

NCT03655041

Sports Nutritional Physiological Phenomena

COMPLETED NA

The Efficacy β-Alanine Supplementation in Performance Outcomes of Road Professional Endurance Cyclists

NCT04427319

Supplementation Cyclists

COMPLETED NA

Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)

NCT06214338

Bioavailability

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After recruitment, subjects will be randomized and assigned to one of the two arms of the study: beta-alanine group or control group (placebo).

Subjects must be active people, and will take a dose of 15 g per day of the product for 4 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Product Safety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Product - Beta Alanine

The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.

Group Type EXPERIMENTAL

Beta-alanine

Intervention Type DIETARY_SUPPLEMENT

The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.

Control group - Placebo

The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.

Group Type PLACEBO_COMPARATOR

Control product consumption

Intervention Type OTHER

Product with identical characteristics to the experimental product. The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Beta-alanine

The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.

Intervention Type DIETARY_SUPPLEMENT

Control product consumption

Product with identical characteristics to the experimental product. The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men between 18 and 40 years of age.
* Physically active people. They must train at least 3 sessions per week.
* Have been training continuously for at least one year.

Exclusion Criteria

* Participant suffering from chronic illness.
* Serious or terminal illness.
* Suffering from a lasting injury that prevents him/her from training in the month prior to the intervention.
* Inability to understand the informed consent.
* Previous experience in the consumption of beta alanine.

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes